Christina Muzny is an Infectious Disease physician. ClinicalTrials.gov lists 4 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1717 6th Ave S
Birmingham, AL 352331801
Telephone
800-822-8816Registry record last updated 29 Jun 2023.
Clinical trials
- Biweekly Long-term Occidiofungin Study for Suppression of Mycotic Recurrence
Sponsor: Sano Chemicals Inc
- Pathogenesis of Bacterial Vaginosis in Women Who Have Sex With Women
Sponsor: University of Alabama at Birmingham
- A Case Control Study of Women With Multiple Sexual Partners
Sponsor: University of Alabama at Birmingham
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year202511 payments$13,149openpaymentsdata.cms.gov ↗
- CepheidProgram year202510 payments$11,915openpaymentsdata.cms.gov ↗
- Abbott LaboratoriesProgram year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
36.9%Gabapentinoids17.3%Gabapentin100%Part D<11 patientsSSRI14.5%Trazodone Hcl61%Escitalopram Oxalate39%Part D<11 patients+ 1 more class in this area
Cardiovascular
24.8%Statin16.8%Rosuvastatin Calcium58%Atorvastatin Calcium42%Part D<11 patientsACE inhibitor7.9%Lisinopril100%Part D<11 patientsAnti-infectives
17.8%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor6.5%Valacyclovir100%Part D<11 patientsGlycopeptide Antibacterial6.1%Vancomycin Hcl100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 2014–2024 per NIH RePORTER. The latest:
- Microbial Interactions between Gardnerella, Prevotella, and Atopobium Prior to Incident Bacterial Vaginosis
University of Alabama at Birmingham
FY2024$601,559R01AI146065 - Microbial Interactions between Gardnerella, Prevotella, and Atopobium Prior to Incident Bacterial Vaginosis
University of Alabama at Birmingham
FY2023$617,292R01AI146065 - The Impact of Testosterone Use on the Vaginal Microbiota in Transgender Men, including Susceptibility to Bacterial Vaginosis
University of Alabama at Birmingham
FY2023$283,494R21AI167754
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Yousef Khader
Jordan University of Science and Technology
Andrew Rambaut
University of Edinburgh
Olayinka Stephen Ilesanmi
University College Hospital
Maysaa El Sayed Zaki
Mansoura University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”